Equity · NYSE · USD

MDT

Medtronic PLC

$82.01

+0.12+0.15%

Live quote

Open: $81.74
High: $82.86
Low: $81.50
Prev close: $81.89

Sector: Healthcare
Industry: Health Care
Size: Mid-cap
Market cap: $105.1B
Shares out: 1.28B
Country: IE
IPO: Nov 21, 1977
Exchange: NYSE
Website: medtronic.com
Next earnings: 2026-08-17 · EPS est. 1.40

Compare →Earnings calendar →

Company briefing

What MDT is

Plain English context — why the name shows up on the tape, and what to watch next. Not a tip.

In plain English

Medtronic PLC makes medical devices and therapies used in hospitals and clinics worldwide. It's a mid-sized company listed on the NYSE.

From the wire

Recent headlines

Live company news for MDT — each headline has a short ClearTape blurb; open the original for the full story.

Medtronic Earnings Preview: What to ExpectIn brief: Medtronic is set to report Q1 earnings, with analysts expecting high single-digit year-over-year EPS growth.Yahoo · Jul 23, 2026
[Latest] Global Implantable Cardiac Fluorine-Free Resins Market Size/Share Worth USD 4.26 Billion by 2035 at a 10.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,SWOT Analysis)In brief[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Implantable Cardiac Fluorine-Free Resins Market size & share revenue was valued at…Yahoo · Jul 23, 2026
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring RevenueIn briefIntuitive Surgical's growth rests on da Vinci 5, Ion, SP and digital tools as recurring revenue rises and procedure risks persist.Yahoo · Jul 22, 2026
ISRG Trends Point to AI, Lung Biopsy Growth and Margin PressureIn briefISRG's growth is fueled by robotic surgery, Ion lung biopsy and AI tools, while tariffs, product mix and softer demand pressure margins.Yahoo · Jul 22, 2026
Is ISRG Stock Worth Buying as Growth Stays Strong but Risks RiseIn briefISRG's strong procedure growth, recurring revenue and cash position support its case, but tariffs, mix shifts and placement risks cloud the outlook.Yahoo · Jul 22, 2026
Orchestra BioMed: Nearing The First Of Two Pivotal ReadoutsIn briefOrchestra BioMed nears pivotal trial readouts for AVIM Therapy & Virtue SAB, backed by Medtronic/Terumo. Click to see catalysts, valuation & upside.SeekingAlpha · Jul 22, 2026
J&J enters US robotic surgery market after device gets marketing authorizationIn briefJohnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic surgery ‌device, as the healthcare conglomerate enters the soft-tissue robotic surgery market.Yahoo · Jul 22, 2026
J&J gets FDA authorization for Ottava robot, teeing up competition with IntuitiveIn briefWhile Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery system will take meaningful share from the market leader.Yahoo · Jul 22, 2026

Same sector

Peers · Healthcare

Latest on this name

Insights & deeper context

Cards tagged with this ticker show up here after ingest.

No insights yet

Search another liquid name, add MDT to your watchlist on the feed, or check back after the next ingest.

Back to feed →

Filings & reports

SEC and filing-linked cards

No filings tagged yet

When SEC ingest runs, 8-K / 10-Q style cards for MDT will show up here.

Indexes like the S&P 500 are shown via liquid ETFs (e.g. SPY). Company profile and quotes use live market data when available.